RE

Rejuvenate Ventures

VC
Boston, MAWebsite
How to approach: warm intro preferred
Stage

seed+, Series A

Check Size

$1.0M – $5.0M

Portfolio

1+ companies

Team

4 partners

Investor activity
Investments in last 12 months: 0

Investment Thesis

Invests in groundbreaking technologies transforming health and longevity by leveraging AI and precision medicine.

Meet the Team

DA

Deborah Ascheim

Chief Medical Officer

ND

Noah Davidsohn

Chief Strategy Officer

DO

Daniel Oliver

Principal Investigator

DE

Dr. Emily Clarke

GP

HealthTech
Longevity

Industry Focus

Invests In

Healthcare
Other

Does Not Invest In

Media
Consumer

Portfolio Companies (1)

Other

AG

AgeTamer

Longevity

Browse More Investors

Frequently Asked Questions

See if Rejuvenate Ventures is a match for your startup

Upload your pitch deck to see how well you match with Rejuvenate Ventures and 200+ other VC firms.